FENC logo

FENC
Fennec Pharmaceuticals Inc

1,319
Mkt Cap
$221.33M
Volume
163,729.00
52W High
$9.92
52W Low
$4.68
PE Ratio
-18.66
FENC Fundamentals
Price
$6.32
Prev Close
$6.42
Open
$6.37
50D MA
$7.68
Beta
0.95
Avg. Volume
227,348.07
EPS (Annual)
-$0.3409
P/B
6.18
Rev/Employee
$1.28M
$184.20
Loading...
Loading...
News
all
press releases
Adherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street Zen
Wall Street Zen cut shares of Adherex Technologies from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Adherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,946 Shares
Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,946 shares of Adherex Technologies stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $6.31, for a total value of $69,069.26. Following the completion of the transaction...
MarketBeat·5d ago
News Placeholder
Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings
Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at HC Wainwright lowered their Q1 2026 earnings estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC...
MarketBeat·7d ago
News Placeholder
HC Wainwright Has Bearish Forecast for FENC Q1 Earnings
Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for shares of Adherex Technologies in a research note issued...
MarketBeat·7d ago
News Placeholder
HC Wainwright Issues Negative Forecast for FENC Earnings
Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Research analysts at HC Wainwright cut their Q3 2026 EPS estimates for shares of Adherex Technologies in a note issued to investors on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings pe...
MarketBeat·7d ago
News Placeholder
HC Wainwright Issues Negative Forecast for TSE:FRX Earnings
Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at HC Wainwright dropped their Q3 2026 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company...
MarketBeat·7d ago
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below 50-Day Moving Average - Should You Sell?
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Below 50-Day Moving Average - Here's Why...
MarketBeat·12d ago
News Placeholder
Adherex Technologies (FENC) to Release Earnings on Wednesday
Adherex Technologies (NASDAQ:FENC) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...
MarketBeat·14d ago
News Placeholder
Adherex Technologies Q4 Earnings Call Highlights
Fennec Pharmaceuticals reported record commercial growth for PEDMARK during its fourth quarter and full year 2025 earnings call, highlighting expanding adoption in both new and existing accounts...
MarketBeat·14d ago
News Placeholder
Adherex Technologies (NASDAQ:FENC) Announces Earnings Results
Adherex Technologies (NASDAQ:FENC - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.18). The business had revenue of $13.78 million during the quarter, compared to analyst...
MarketBeat·14d ago
<
1
2
...
>

Latest FENC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.